BRIEF-Qualigen Therapeutics Announces Management Changes

Reuters09-27

Sept 26 (Reuters) - Qualigen Therapeutics Inc :

* QUALIGEN THERAPEUTICS, INC. ANNOUNCES MANAGEMENT CHANGES.

* QUALIGEN THERAPEUTICS INC - APPOINTED CAMPBELL BECHER AS PRESIDENT

* QUALIGEN THERAPEUTICS INC - CHRISTOPHER LOTZ, CHIEF FINANCIAL OFFICE ALSO TENDERED HIS RESIGNATION FROM COMPANY

* QUALIGEN THERAPEUTICS INC - APPOINTED KEVIN RICHARDSON AS INTERIM CEO AND CFO AS WELL AS A MEMBER OF BOARD

* QUALIGEN THERAPEUTICS INC: MICHAEL POIRIERTO RESIGN AS CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF BOARD OF COMPANY, EFFECTIVE IMMEDIATELY

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470932377?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-27 05:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2470932377","market":"us","top_or_hot":-1,"title":"BRIEF-Qualigen Therapeutics Announces Management Changes","media":"Reuters","content":"<html><body><p>Sept 26 (Reuters) - Qualigen <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * QUALIGEN THERAPEUTICS, INC. ANNOUNCES MANAGEMENT CHANGES.</p><p>   * QUALIGEN THERAPEUTICS INC - APPOINTED CAMPBELL BECHER AS PRESIDENT</p><p>   * QUALIGEN THERAPEUTICS INC - CHRISTOPHER LOTZ, CHIEF FINANCIAL OFFICE ALSO TENDERED HIS RESIGNATION FROM COMPANY</p><p>   * QUALIGEN THERAPEUTICS INC - APPOINTED KEVIN RICHARDSON AS INTERIM CEO AND CFO AS WELL AS A MEMBER OF BOARD</p><p>   * QUALIGEN THERAPEUTICS INC:  MICHAEL POIRIERTO RESIGN AS CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF BOARD OF COMPANY, EFFECTIVE IMMEDIATELY</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Qualigen Therapeutics Announces Management Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Qualigen Therapeutics Announces Management Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-27 05:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sept 26 (Reuters) - Qualigen Therapeutics Inc   :   * QUALIGEN THERAPEUTICS, INC. ANNOUNCES MANAGEMENT CHANGES.   * QUALIGEN THERAPEUTICS INC - APPOINTED CAMPBELL BECHER AS PRESIDENT   * QUALIGEN ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2470932377","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470932377","pubTimestamp":1727385771,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 26  - Qualigen Therapeutics Inc   :   * QUALIGEN THERAPEUTICS, INC. ANNOUNCES MANAGEMENT CHANGES.   * QUALIGEN THERAPEUTICS INC - APPOINTED CAMPBELL BECHER AS PRESIDENT   * QUALIGEN THERAPEUTICS INC - CHRISTOPHER LOTZ, CHIEF FINANCIAL OFFICE ALSO TENDERED HIS RESIGNATION FROM COMPANY   * QUALIGEN THERAPEUTICS INC - APPOINTED KEVIN RICHARDSON AS INTERIM CEO AND CFO AS WELL AS A MEMBER OF BOARD   * QUALIGEN THERAPEUTICS INC:  MICHAEL POIRIERTO RESIGN AS CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF BOARD OF COMPANY, EFFECTIVE IMMEDIATELYSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","QLGN":"Qualigen Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"简介-Qualigen Therapeutics宣布管理层变动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"QLGN":0.9},"content_text":"Sept 26 (Reuters) - Qualigen Therapeutics Inc   :   * QUALIGEN THERAPEUTICS, INC. ANNOUNCES MANAGEMENT CHANGES.   * QUALIGEN THERAPEUTICS INC - APPOINTED CAMPBELL BECHER AS PRESIDENT   * QUALIGEN THERAPEUTICS INC - CHRISTOPHER LOTZ, CHIEF FINANCIAL OFFICE ALSO TENDERED HIS RESIGNATION FROM COMPANY   * QUALIGEN THERAPEUTICS INC - APPOINTED KEVIN RICHARDSON AS INTERIM CEO AND CFO AS WELL AS A MEMBER OF BOARD   * QUALIGEN THERAPEUTICS INC:  MICHAEL POIRIERTO RESIGN AS CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF BOARD OF COMPANY, EFFECTIVE IMMEDIATELYSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470932377"}